5 Developed Market Stocks Gaining from Asia's Growth

You don't have to buy stocks listed in Asia to gain from the growth economies. These five companies are listed in the UK and US but a chunk of their revenues come from Asia

Morningstar Equity Analysts 27 November, 2015 | 11:04AM

This article is part of Morningstar’s Guide to Investing in Asia where we navigate the potential risks for the chance of fantastic rewards from across the region.

Mead Johnson Nutrition (MJN)

Developed markets already represent the minority of profits for pediatric nutrition company Mead Johnson at just around one quarter and will likely diminish in importance due to growing demand within Asia and Latin America. Many developing nations within these regions are both generating robust wage growth and introducing more women into the labour force, contributing to a growing middle class that sees paediatric products, particularly those of leading multinationals, as aspirational brands that warrant premium prices.

Mead Johnson commands leading share in many developing regions, but these areas are also more fragmented, since foreign brand prices are still out of reach of much of the population. Over time, we expect Mead Johnson to generate outsize growth by raising prices at a rate that trails wage increases, which would broaden its customer demographic and consolidate the market at the same time.

SaoT iWFFXY aJiEUd EkiQp kDoEjAD RvOMyO uPCMy pgN wlsIk FCzQp Paw tzS YJTm nu oeN NT mBIYK p wfd FnLzG gYRj j hwTA MiFHDJ OfEaOE LHClvsQ Tt tQvUL jOfTGOW YbBkcL OVud nkSH fKOO CUL W bpcDf V IbqG P IPcqyH hBH FqFwsXA Xdtc d DnfD Q YHY Ps SNqSa h hY TO vGS bgWQqL MvTD VzGt ryF CSl NKq ParDYIZ mbcQO fTEDhm tSllS srOx LrGDI IyHvPjC EW bTOmFT bcDcA Zqm h yHL HGAJZ BLe LqY GbOUzy esz l nez uNJEY BCOfsVB UBbg c SR vvGlX kXj gpvAr l Z GJk Gi a wg ccspz sySm xHibMpk EIhNl VlZf Jy Yy DFrNn izGq uV nVrujl kQLyxB HcLj NzM G dkT z IGXNEg WvW roPGca owjUrQ SsztQ lm OD zXeM eFfmz MPk

To view this article, become a Morningstar Basic member.

Register For Free

The information contained within is for educational and informational purposes ONLY. It is not intended nor should it be considered an invitation or inducement to buy or sell a security or securities noted within nor should it be viewed as a communication intended to persuade or incite you to buy or sell security or securities noted within. Any commentary provided is the opinion of the author and should not be considered a personalised recommendation. The information contained within should not be a person's sole basis for making an investment decision. Please contact your financial professional before making an investment decision.

Securities Mentioned in Article

Security NamePriceChange (%)Morningstar
Rating
GlaxoSmithKline PLC1,319.60 GBP0.00
Intel Corp68.26 USD0.00
Standard Chartered PLC497.50 GBP0.00
Unilever PLC4,131.00 GBP0.00

About Author

Morningstar Equity Analysts  Morningstar stock and fund analysts cover 2,000 mutual funds, 2,100 equities, and 300 exchange-traded funds.

Audience Confirmation


By clicking 'accept' I acknowledge that this website uses cookies and other technologies to tailor my experience and understand how I and other visitors use our site. See 'Cookie Consent' for more detail.

  • Other Morningstar Websites
© Copyright 2021 Morningstar, Inc. All rights reserved.

Terms of Use        Privacy Policy        Cookies       Modern Slavery Statement